Harlem Capital Partners
A software platform maker that automates common care-management tasks so that care providers can better serve patients.
Love Your Melon
An apparel brand that gives 50 percent of its profits to organizations helping to fight pediatric cancer.
Uses its own DETECTR system to detect genes associated with disease. It joins a family of CRISPR systems developed by Mammoth to provide enhanced genome editing for industries like health care, research, agriculture, and even biodefense.
Molecular diagnostics--scanning DNA for genes associated with disease--is the most accurate method of early disease detection, but usually requires large, expensive laboratory facilities and trained experts, slowing results. Mammoth’s DETECTR tool was built to bypass many of those obstacles to rapid testing, and in January, the company reconfigured DETECTR to make the first CRISPR-based test for Covid-19. The test is a low-cost option that produces highly accurate results in just 30 minutes--instead of the 24-hour minimum required by many other tests.